Acute myocardial injury, MINOCA, or myocarditis? Improving characterization of coronavirus-associated myocardial involvement.
作者信息
Peretto Giovanni, Sala Simone, Caforio Alida Linda Patrizia
机构信息
Department of Cardiac Electrophysiology and Arrhythmology, Myocarditis Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
出版信息
Eur Heart J. 2020 Jun 7;41(22):2124-2125. doi: 10.1093/eurheartj/ehaa396.
Abstract
摘要
相似文献
1
Acute myocardial injury, MINOCA, or myocarditis? Improving characterization of coronavirus-associated myocardial involvement.急性心肌损伤、冠状动脉非阻塞性心肌梗死还是心肌炎？改善对冠状病毒相关心肌受累情况的特征描述。
Eur Heart J. 2020 Jun 7;41(22):2124-2125. doi: 10.1093/eurheartj/ehaa396.
2
Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection.一名感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的患者出现急性心肌炎，表现为反向Tako-Tsubo综合征。
Eur Heart J. 2020 May 14;41(19):1861-1862. doi: 10.1093/eurheartj/ehaa286.
3
Does SARS-CoV-2 cause viral myocarditis in COVID-19 patients?严重急性呼吸综合征冠状病毒2（SARS-CoV-2）会导致新冠肺炎患者发生病毒性心肌炎吗？
Eur Heart J. 2020 Jun 7;41(22):2123. doi: 10.1093/eurheartj/ehaa392.
4
Takotsubo cardiomyopathy and COVID-19 infection.应激性心肌病与新型冠状病毒肺炎感染
Eur Heart J Cardiovasc Imaging. 2020 Oct 20;21(11):1299-1300. doi: 10.1093/ehjci/jeaa236.
5
COVID-19 associated viral myocarditis: does it exist?新型冠状病毒肺炎相关的病毒性心肌炎：它存在吗？
Monaldi Arch Chest Dis. 2020 Sep 9;90(4). doi: 10.4081/monaldi.2020.1382.
6
[Takotsubo syndrome during SARS-CoV-2 pneumonia: a possible cardiovascular complication].新型冠状病毒肺炎期间的应激性心肌病：一种可能的心血管并发症
G Ital Cardiol (Rome). 2020 Jun;21(6):417-420. doi: 10.1714/3359.33323.
7
Letter by Finsterer Regarding Article, "COVID-19-Associated Stress (Takotsubo) Cardiomyopathy".芬斯特勒就《COVID-19相关应激（应激性心肌病）》一文所写的信。
Circ Cardiovasc Imaging. 2020 Oct;13(10):e011577. doi: 10.1161/CIRCIMAGING.120.011577. Epub 2020 Sep 23.
8
COVID-19-Associated Stress (Takotsubo) Cardiomyopathy.新型冠状病毒肺炎相关应激性（应激性心肌病）心肌病
Circ Cardiovasc Imaging. 2020 Jul;13(7):e011222. doi: 10.1161/CIRCIMAGING.120.011222. Epub 2020 Jul 15.
9
Acute Fulminant Myocarditis in a Pediatric Patient With COVID-19 Infection.儿童 COVID-19 感染患者的急性暴发性心肌炎。
Pediatrics. 2020 Aug;146(2). doi: 10.1542/peds.2020-1509.
10
Myocardial Injury in COVID-19 Patients: The Beginning or the End?新冠病毒肺炎患者的心肌损伤：是开端还是结局？
J Am Coll Cardiol. 2020 Aug 4;76(5):547-549. doi: 10.1016/j.jacc.2020.06.045.
引用本文的文献
1
COVID-19 and Myocarditis: Trends, Clinical Characteristics, and Future Directions.新型冠状病毒肺炎与心肌炎：趋势、临床特征及未来方向
J Clin Med. 2025 Jun 27;14(13):4560. doi: 10.3390/jcm14134560.
2
Cardiovascular Outcomes in Hospitalized Patients with COVID-19: Does Age Really Matter?新冠肺炎住院患者的心血管结局：年龄真的重要吗？
J Cardiovasc Dev Dis. 2025 Jan 24;12(2):41. doi: 10.3390/jcdd12020041.
3
Navigating the COVID-19 Therapeutic Landscape: Unveiling Novel Perspectives on FDA-Approved Medications, Vaccination Targets, and Emerging Novel Strategies.探索新冠病毒治疗领域：揭示关于美国食品药品监督管理局批准药物、疫苗接种目标及新兴策略的新观点
Molecules. 2024 Nov 25;29(23):5564. doi: 10.3390/molecules29235564.
4
Comparison between myocardial infarction with non-obstructive coronaries (MINOCA) and myocardial infarct patients with coronary artery disease (MI-CAD): A single-center retrospective cohort study.非阻塞性冠状动脉心肌梗死（MINOCA）与冠心病心肌梗死患者（MI-CAD）的比较：一项单中心回顾性队列研究。
Caspian J Intern Med. 2024 Winter;15(1):109-114. doi: 10.22088/cjim.15.1.12.
5
COVID-19 and cardiovascular complications: updates of emergency medicine.新型冠状病毒肺炎与心血管并发症：急诊医学的最新进展
Emerg Crit Care Med. 2023 Sep;3(3):104-114. doi: 10.1097/ec9.0000000000000095. Epub 2023 Jun 1.
6
High expression of IL6 and decrease in immune cells in COVID-19 patients combined with myocardial injury.新冠病毒肺炎合并心肌损伤患者中白细胞介素6高表达及免疫细胞减少。
Front Immunol. 2023 Jul 26;14:1190644. doi: 10.3389/fimmu.2023.1190644. eCollection 2023.
7
SARS-CoV-2 Related Myocarditis: What We Know So Far.新型冠状病毒2型相关心肌炎：目前我们所了解的情况。
J Clin Med. 2023 Jul 15;12(14):4700. doi: 10.3390/jcm12144700.
8
Advancements of Nanotechnology and Nanomaterials in Environmental and Human Protection for Combatting the COVID-19 During and Post-pandemic Era: A Comprehensive Scientific Review.纳米技术和纳米材料在疫情期间及大流行后时代对抗COVID-19的环境与人类防护中的进展：全面科学综述
Biomed Mater Devices. 2023 May 10:1-24. doi: 10.1007/s44174-023-00086-9.
9
COVID-19 Vaccines and Myocarditis: An Overview of Current Evidence.2019冠状病毒病疫苗与心肌炎：当前证据概述
Biomedicines. 2023 May 17;11(5):1469. doi: 10.3390/biomedicines11051469.
10
Acute and Post-Acute COVID-19 Cardiovascular Complications: A Comprehensive Review.急性和新冠病毒感染后心血管并发症：全面综述。
Cardiovasc Drugs Ther. 2024 Oct;38(5):1017-1032. doi: 10.1007/s10557-023-07465-w. Epub 2023 May 20.
本文引用的文献
1
Endothelial cell infection and endotheliitis in COVID-19.新型冠状病毒肺炎中的内皮细胞感染与内皮炎
Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.
2
Myocardial localization of coronavirus in COVID-19 cardiogenic shock.COVID-19 心原性休克中冠状病毒的心肌定位。
Eur J Heart Fail. 2020 May;22(5):911-915. doi: 10.1002/ejhf.1828. Epub 2020 Apr 11.
3
Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection.一名感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的患者出现急性心肌炎，表现为反向Tako-Tsubo综合征。
Eur Heart J. 2020 May 14;41(19):1861-1862. doi: 10.1093/eurheartj/ehaa286.
4
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.心肌炎的病因、诊断、治疗和治疗的现有知识状况：欧洲心脏病学会心肌和心包疾病工作组的立场声明。
Eur Heart J. 2013 Sep;34(33):2636-48, 2648a-2648d. doi: 10.1093/eurheartj/eht210. Epub 2013 Jul 3.
5
Acute biopsy-proven lymphocytic myocarditis mimicking Takotsubo cardiomyopathy.经活检证实的急性淋巴细胞性心肌炎，酷似应激性心肌病。
Eur J Heart Fail. 2009 Apr;11(4):428-31. doi: 10.1093/eurjhf/hfp008. Epub 2009 Feb 3.
Zotero 插件